BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3730768)

  • 21. Abnormalities of the liver evaluated by 31P MRS.
    Meyerhoff DJ; Karczmar GS; Weiner MW
    Invest Radiol; 1989 Dec; 24(12):980-4. PubMed ID: 2606636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique aspects of human newborn cerebral metabolism evaluated with phosphorus nuclear magnetic resonance spectroscopy.
    Younkin DP; Delivoria-Papadopoulos M; Leonard JC; Subramanian VH; Eleff S; Leigh JS; Chance B
    Ann Neurol; 1984 Nov; 16(5):581-6. PubMed ID: 6508240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro 31P magnetic resonance spectroscopic studies of the hepatic response of healthy rats and rats with acute hepatic damage to fructose loading.
    Lu W; Locke SJ; Brauer M
    Magn Reson Med; 1994 May; 31(5):469-81. PubMed ID: 8015399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive quantitation of human liver metabolites using image-guided 31P magnetic resonance spectroscopy.
    Meyerhoff DJ; Karczmar GS; Matson GB; Boska MD; Weiner MW
    NMR Biomed; 1990 Feb; 3(1):17-22. PubMed ID: 2390449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The 31P-NMR study of the metabolism of phosphate-containing compounds in the rat liver during inhibition of protein synthesis].
    Iushmanov VE; Mitrokhin IuI; Iukhnevich MG; Todorov IN; Sibel'dina LA
    Biokhimiia; 1986 Jul; 51(7):1203-9. PubMed ID: 3730450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of hepatic impairment on the metabolism of fructose and 5-fluorouracil, as studied in fatty liver models using in vivo 31P-MRS and 19F-MRS.
    Otsuka H; Harada M; Koga K; Nishitani H
    Magn Reson Imaging; 1999 Feb; 17(2):283-90. PubMed ID: 10215484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo 31P-NMR studies on energy metabolism in and catecholamine effect on rat liver during hypovolemic shock.
    Okuda M; Muneyuki M; Nakashima K; Sogabe T; Miura I
    Biochem Int; 1987 Dec; 15(6):1089-95. PubMed ID: 3440021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo monitoring of fructose metabolism in the human liver by means of 31P magnetic resonance spectroscopy.
    Segebarth C; Grivegnée AR; Longo R; Luyten PR; den Hollander JA
    Biochimie; 1991 Jan; 73(1):105-8. PubMed ID: 2031955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo (31)P magnetic resonance spectroscopy of the human liver at 7 T: an initial experience.
    Chmelik M; Považan M; Krššák M; Gruber S; Tkačov M; Trattnig S; Bogner W
    NMR Biomed; 2014 Apr; 27(4):478-85. PubMed ID: 24615903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of functional recovery of regenerating rat liver after partial hepatectomy using 31P-NMR spectroscopy.
    Nishida Y; Tanaka K; Munakata T; Kasai S
    J Surg Res; 1996 Mar; 61(2):385-90. PubMed ID: 8656613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adenine on liver nucleotide after fructose loading by 31P-NMR.
    Thoma WJ; Uğurbil K
    Am J Physiol; 1989 Jun; 256(6 Pt 1):G949-56. PubMed ID: 2500027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases.
    Brinkmann G; Melchert UH; Lalk G; Emde L; Link J; Muhle C; Steffens JC; Heller M
    Invest Radiol; 1997 Feb; 32(2):100-4. PubMed ID: 9039582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy.
    Kiyono K; Shibata A; Sone S; Watanabe T; Oguchi M; Shikama N; Ichijo T; Kiyosawa K; Sodeyama T
    Acta Radiol; 1998 May; 39(3):309-14. PubMed ID: 9571950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorus-31 MRS of the kidney.
    Hricak H
    Invest Radiol; 1989 Dec; 24(12):993-6. PubMed ID: 2691445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intravenous fructose on the P-31 MR spectrum of the liver: dose response in healthy volunteers.
    Terrier F; Vock P; Cotting J; Ladebeck R; Reichen J; Hentschel D
    Radiology; 1989 May; 171(2):557-63. PubMed ID: 2704824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient.
    Bashir A; Gropler R; Ackerman J
    PLoS One; 2015; 10(12):e0143239. PubMed ID: 26633549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scanner.
    Laufs A; Livingstone R; Nowotny B; Nowotny P; Wickrath F; Giani G; Bunke J; Roden M; Hwang JH
    Magn Reson Med; 2014 May; 71(5):1670-5. PubMed ID: 23798380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
    Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
    Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic changes in the cornea of vitamin A-deficient rats.
    Hayashi K; Cheng HM; Xiong J; Xiong H; Kenyon KR
    Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):769-72. PubMed ID: 2703320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The involvement of fructose 2,6-bisphosphate in substrate cycle control in the nonoxidative stage of the pentose phosphate pathway. A phosphorus magnetic resonance spectroscopy study.
    Belyaeva NF; Golubev MA; Grigorovich JA; Dubinsky ZV; Semenova NA; Pitkänen E; Korovkin BF
    Experientia; 1994 Aug; 50(8):780-4. PubMed ID: 8070536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.